Geriatric Assessment: How can we increase implementation?

摘要

A geriatric assessment (GA) is now recommended by for all older adults receiving chemotherapy, in a clinical practice guideline released by the American Society of Clinical Oncology (ASCO). As the accompanying review article discusses, GA can detect vulnerabilities not identified by a routine onco-logic assessment, and it outperforms common tools such as the Eastern Cooperative Oncology Group CECOG) and Karnofsky performance status in predicting outcomes including survival and chemotherapy toxicity.